Eye disease study tracks 5-Year outcomes and recurrence risks
NCT ID NCT03929731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 72 people with polypoidal choroidal vasculopathy (PCV), an eye condition that can cause vision loss, for 5 years after their first treatment. Researchers wanted to see how often the disease comes back, what treatments were needed, and if early treatment success led to better long-term vision. The goal is to help doctors predict outcomes and plan better care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
72 people
The number who actually took part.
- Started
-
Jul 2019
- Finished
-
May 2024
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T\&E studies
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T\&E studies * Are able to give consent for this follow up study Exclusion Criteria: * No exclusion criteria unless they do not meet the inclusion criteria
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Polypoidal choroidal vasculopathy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National University Hospital
Singapore, Singapore
-
Singapore National Eye Centre
Singapore, Singapore, 168751, Singapore
-
Tan Tock Seng Hospital
Singapore, Singapore, 308433, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.